be due to the accelerated immune reconstitution (PHA mitogenesis, NK activity, and CD4:CD8 ratio) which is observed following HDT and PSCT as compared to Rapid immune reconstitution is observed following autologous peripheral blood stem cell transplantation ABMT. 7,8 Although there have been limited and conflicting studies on immune reconstitution following PSCT and (PSCT) as compared to autologous bone marrow transplantation (ABMT), although it is depressed compared ABMT,[8][9] [10] [11] all these studies have reported an impairment in T cell function following transplantation with an inverto that observed in normal individuals. The immune dysfunction occurs despite the restoration of normal sion in the CD4:CD8 cell ratio and a reduced T cell proliferative response. Studies have also suggested that there lymphoid cell numbers and may be associated with the immunologic characteristics of the infused peripheral are differences in immune cell phenotype and function amongst the various apheresis/transplant products.
rapid following PSCT, using growth factor mobilized PSC We previously reported a significant depression in T cell products, as compared to steady-state bone marrow autoproliferation (PHA mitogenesis) and T helper cell activity grafts. 3, 4 In addition, a retrospective study of non-Hodgkin (PWM mitogenesis) in PSC products 12, 25 and in the PBL lymphoma patients demonstrated a significant increase in following transplantation, 7,8 as well as significant levels of the progression-free interval following PSCT, using steadycellular T cell inhibitory activity. 7, 8, 12, 25 Because of the T state apheresis products, as compared to ABMT, 5 although cell inhibitory activity of the cells in the PSC products and this observation requires confirmation in a prospectively their potential to delay the immune reconstitution of PSCT randomized trial. 6 This perceived therapeutic benefit may patients, 7, 8 we examined the role of this cellular function in the regulation of lymphocyte function in PSC products. These studies focused on the regulatory role of monocytes 
Materials and methods
100, 30 or 10 U/ml. On day 3 (PHA) or on day 5 (IL-2), the wells were pulsed for 24 h with 1 Ci of 3 H-thymidine (Amersham Life Sciences, Arlington Heights, IL, USA).
Preparation of cells
The cells were harvested on day 4 (PHA) or on day 6 (IL-PSC from the third or fourth apheresis were collected from 2) using an automatic multi-well harvester (Packard Instru-29 breast cancer patients following GM-CSF mobilization ments, Downers Grove, IL, USA). The filters were allowed at 200 g/m 2 . We utilized the third and fourth apheresis to air dry, scintillation cocktail added, and the samples collections to reduce any potential variability associated counted in a Packard multi-well beta-plate counter. The with different apheresis collections and to be consistent mean counts per minute (c.p.m.) ± the standard error of with our previous studies. 7, 8, 12, 25 Patients who were eligible the mean (s.e.) are plotted. The stimulation index (SI) was for PSCT at the University of Nebraska Medical Center calculated as the ratio of experimental c.p.m./control c.p.m. (UNMC) were entered into these studies. These samples were obtained using protocols approved by the Institutional Assay of T cell inhibitory activity Review Board of UNMC and following written informed consent. Peripheral blood mononuclear cells (PBMC) were
The co-culture assay to measure T cell inhibitory activity obtained by centrifugation over a Ficoll-Hypaque gradient.
has been described previously. control) starting at an inhibitor to responder cell (I:R) ratio g/ml gentamycin and 10% human AB serum (Sigma of 4:1 and an optimal concentration of PHA (0.5 g/ml). Chemical, St Louis, MO, USA).
Four, two-fold dilutions of inhibitor cells (50 l) were made in 96-well flat bottom plates. The responder cells were then added (50 l) together with the PHA (100 l).
Elimination of phagocytic cells
Cells were cultured at 37°C (5% CO 2 ) for 4 days in RPMICarbonyl-iron (CI) [26] [27] [28] was used with the PSC samples to 1640 medium 10% FBS and the mitogenic response by the obtain a lymphocyte-enriched and CD14
+ cell-depleted responder population assayed by pulsing with 1 Ci/well population. Sterile CI power (0.125 mg/ml) was added to 3 H-thymidine over the final 18 h of culture. Cells were harthe cell suspension at a concentration of 5-6 × 10 6 cells/ml vested with a multiwell harvester onto fiberglass strips and in a 50 cm 2 tissue culture flask. After incubation on a rocker the radioactivity determined in a Packard beta scintillation platform at 37°C and 5% CO 2 for 60 min, a sterile magnet counter as described above. was introduced and the cell suspension incubated for an additional 5 min. The remaining cells were then collected Flow cytometry and washed in HBSS. Residual iron-loaded mononuclear phagocytes were removed by magnetic isolated using a Three-color FACS analyses were used for the phenotyping MiniMac (Miltenyi Biotech; Auburn, CA, USA) separstudies. Aliquots of 5 × 10 4 cells were stained with a variety ation column.
of monoclonal antibody cocktails to human lymphocyte and/or myelocyte antigens. The cocktails consisted of two directly labeled antibodies (one labeled with fluorescein Cell culture (FITC) (CD3) and the other with phycoerythrin (PE) (CD4, The cell proliferative abilities of the lymphocytes from the CD56)), and a biotin conjugated third antibody (CD8, PSC product were determined by culture at 1.5 × 10 6 CD19, CD14). After incubation and washing, streptavidin cells/ml (n = 18) in complete medium in a final volume allophycocyanine cross linked conjugate (APC) was added of 2 ml in 24-well plates (Falcon; Becton Dickinson, Los as the third fluorochrome. All three color data were Angeles, CA, USA). In addition, some PSC products were acquired on a FACStar Plus using a 40 mW 488 nm argon cultured at 3.8 × 10 5 cells/ml in complete medium (n = 11) laser and a 100 mW 647 nm HeNe laser for excitation. in a final volume of 13 ml in six-well plates (Falcon;
Detailed three-color data analysis was performed using Becton Dickinson). Recombinant human IL-2 (Chiron, Paint-A-Gate Plus software from Becton Dickinson. Emeryville, CA, USA) was added to a final concentration of 12 IU/ml (low concentration) or 40 IU/ml (high Natural killer (NK) cytotoxicity assay concentration). Cells were incubated in a humidified 37°C incubator with 5% CO 2 for 21 days. The cultures were refed Cytotoxic activity of the cell preparations was tested against every 3-4 days with medium containing IL-2.
the NK-sensitive myeloid leukemia cell line, K-562, in a 4-h 51 Cr release assay. Target cells (1 × 10 7 cells) were labeled with 100 Ci
51
Cr for 1 h at 37°C. After washing to remove Mitogen induced proliferation assay unbound radioactivity, labeled target cells were then added to the wells of round bottom 96-well plates and incubated Cells (100 l/well) were plated in quadruplicate in flatbottomed wells of microtiter plates at 1 × 10 6 cells/ml. The at effector-to-target cell ratios ranging from 100:1 to 25:1. Maximum and spontaneous release were determined by incucells were cultured in PHA (100 l/well) at a final concentration of 1.25, 0.3 or 0.07 g/ml or r-IL-2 at 1000, 300, bating the tumor cells with 2% Triton-X-100 or medium alone, respectively. All determinations were made in quadbefore and after treatment with CI. The results in Table 2 show that the treatment with CI significantly inhibited T ruplicate. Radioactivity was counted in a gamma counter following harvest using a Skatron supernatant harvester cell inhibitory activity (P = 0.0001 at 2:1 and P = 0.021 at a 1:1 I:R ratio), suggesting that the cells responsible for T (Sterling, VA, USA). Cytotoxicity was calculated as:
cell inhibitory activity were phagocytic and likely of monocytic lineage. Furthermore, the inhibition of T cell prolifer-% specific lysis = ation in response to PHA by the cells from the PSC products was significantly abrogated when monocytes were 
Monocytes prevent the expansion of lymphocytes to IL-2 Statistical analysis in the PSC products from breast cancer patients
The effect of monocytes on lymphocyte expansion in SPSS for Windows (Chicago, IL, USA) was used to employ response to IL-2 by the cells in the PSC products was also the independent samples t test for the difference between investigated. PSC samples were treated with CI and comtwo independent means. Mean differences were considered pared to untreated samples, following culture in vitro with significant when P р 0.05.
IL-2 at low doses (12 U/ml; n = 29) or high doses (40 U/ml; n = 11). Analyses of the number of cultured cells and their viability were performed on days 7, 14 and 21 of Results culture. Lymphocyte proliferation was significantly depressed by the presence of monocytes as compared to Depletion of monocytes monocyte-depleted cultures. The number of cells increased 1.8-fold on day 7, 4.6-fold on day 14 and 7.5-fold on day Depletion of mononuclear phagocytes from the leukocytes 21 in the monocyte-depleted cultures compared to unmanof PSC products was accomplished using CI and magnetic ipulated cultures (Figure 2 ). A significant difference was removal of phagocytic cells which had ingested CI. In order observed between the monocyte-depleted and undepleted to determine the specificity of this technique, [26] [27] [28] flow cytometric analysis of the separated cell populations were undertaken. As shown in Table 1 , this method was rela- product) starting at an inhibitor to responder (I:R) ratio of 2:1 and an optimal concentration of PHA. The PSC products were analyzed intact or following carbonyl iron (CI) depletion of phagocytic CD14 + cells (n = 25 samples with three replicate of each sample). 
Phagocytic cells from PSC products possess T cell

CD14
+ monocytes from PSC products on T cell inhibitory d
Significant difference in inhibition compared to non-CI treated PSC products (P р 0.05).
activity, a comparison was made between PSC samples
The mitogenic dose-dependent response of the primary cultured cells in response to exogenous IL-2 stimulation was also tested on days 7, 14 and 21 of culture as well as at time 0. Significant differences in the dose-response to secondary IL-2 mitogenesis was noted between cells cultured with and without monocytes. Similar to the uncultured and unseparated PBMC populations (time 0), cells cultured with monocytes failed to proliferate after stimulation with varying doses of IL-2 on days 7, 14 (results not shown), and 21 of culture (Figure 3) (Table 3) with or without monocytes, respectively. Thus, the presence of monocytes not only inhibits cell proliferation but also on the basis of cell numbers ( Figure 2 ) and frequency reduces the absolute T cell numbers in the to cells from the unmanipulated product cultures. As shown in Figure 4 , cells from intact PSC products demonstrated significantly lower NK cell activity compared to CI treated PSC products at E:T ratios of 40:1, 20:1 and 10:1. NK cell activity was significantly augmented by exogenous IL-2 on day 7 (P Ͻ 0.0001 at 40:1) to day 21 of culture (data not shown) compared to time 0. Furthermore, cells depleted of monocytes and co-cultured with IL-2 had significantly increased NK activity compared to cultures of intact PSC product cells, although both had augmented NK activity compared to time zero. This is consistent with the increased frequency of CD56 + cells observed following culture without monocytes (38.3%) vs with monocytes (5.2%) on day 7. The difference in NK activity is unlikely to be due to the difference in NK cells in the product at the initiation of culture as their frequency was 4% in the non-CI cells and 6% in the CI-treated products. patients (results not shown). This paper extends our earlier studies in which we demonstrated the existence of high levels of T cell inhibitory activity in PSC products and the PB postcultures on day 7 (P = 0.011), day 14 (P = 0.016) and day 21 (P = 0.023). Further, inhibition of lymphocyte expansion transplant. 7, 8, 12, 25 Although the active suppression of T cell function has been extensively investigated, the cellular and in response to IL-2 in non-monocyte-depleted PBMC cultures could not be overcome with higher doses (40 U/ml) molecular basis has not been well defined. Various cell fractionation techniques have been used to remove and characof IL-2 (Figure 2) . No CI 31% ± 9 16% ± 5 11% ± 4 40% ± 12 5% ± 1 CI 67% ± 6 terize this population. Several reports have shown that the inhibition of T cell function can be mediated by a cell population having the characteristics of monocytes and phenotypic markers common to the monocyte lineage. [19] [20] [21] [22] [23] [24] [29] [30] [31] [32] [33] [34] [35] [36] Monocytes and macrophages play an important role in the regulation of immunity, both by direct cellular interactions and by the secretion of soluble factors. [32] [33] [34] [35] It has been suggested that monocytes can also exert a negative control resulting in an inhibition of IL-2 production and IL-2 stimulation. 22, 37 Munn et al 22 suggested that antigen-presenting cells (APC) can selectively delete mature T cells at a point before their clonal expansion. In this study, a form of activation-induced T cell death (apoptosis) was proposed. They found that proliferation was inhibited by macrophage-CSF (M-CSF) derived macrophages in a contact-dependent manner. The macrophage-associated apoptosis was characterized as affecting resting T cells before blastogenesis and cell division, and preventing the functional activation and clonal expansion of T cells. We demonstrate herein that CD14 + phagocytic cells are suppressive for normal T cell 14) and following 7 day incubation (̄,̆) (n = 9) in IL-2 (12 U/ml).
Because the relapse rate is significantly lower after stem Cytotoxicity was assessed by a 4-h 51 Cr release assay with K562 serving as the target cells at different E:T ratios.
cell allogeneic transplantation compared to autologous transplantation, 38 we are interested in strategies to augment were undertaken with GM-CSF mobilized PSC products, similar results have been observed with G-CSF mobilized immune recovery following autologous transplantation. One such approach is the use of an adjuvant immunotherproducts obtained from normal donors (results not shown).
In addition, increased levels of T cell inhibitory activity apy with IL-2 after autologous transplantation as a means of eradicating residual disease.
39-43 A number of studand monocyte frequency, are observed in apheresis products obtained from nonmobilized normal donors. 12 We ies 12, 13, 42, 43 have evaluated NK activity in BM and mobilized apheresis stem cell products. NK cells are sponsuggest that any product with an increased frequency of monocytes will express heightened T cell inhibitory taneously cytotoxic for a variety of fresh and cultured tumor cells and this activity can be augmented by treatment activity. Indeed, in other studies, we found a linear relationship between T cell inhibitory activity and the frequency with IL-2. 44 Verbik et al 13 studied the immunophenotypic and NK cytotoxicity characteristics of consecutive PSC colof monocytes. 25 In conclusion, we suggest that the removal of monocytes lections from cancer patients mobilized with GM-CSF as compared to PB obtained from normal donors. They found from GM-CSF mobilized PSC products of breast cancer patients results in a better response to IL-2 with an that the NK cytotoxicity levels in the PB from normal donors was significantly greater, after in vitro activation increased proliferative capacity and improved T and NK cell function. Further studies are needed to identify the with IL-2, compared with PSC obtained from either normal donors or cancer patients. Similar results were found in our mechanism involved in this inhibition; although, other studies from our laboratory have clearly demonstrated that studies 12 in which we observed a significant decrease in NK activity from steady-state PSC products compared to monocytes have a role. 25 The observation of T and NK cell inhibitory activity within the PSC products suggest that normal PBL in the presence of a high frequency of monocytes and T cell inhibitory activity. Verbik et al 13 also monocytes may not only block the in vitro response of lymphocytes to IL-2, but also reduce immune reconstitution reported that earlier apheresis collections had significantly greater NK activity after in vitro culture with IL-2 as comand response to adjuvant immunotherapy. pared to the later collections. Further, they found that later collections which contained a higher percentage of CD56 additional studies are necessary, we suggest that the increased NK cytotoxicity activity in early apheresis collections might be associated with a lower frequency of monoReferences cytes in these apheresis products.
The present study suggests that the monocytes in mobil- 
